INOVIO PHARMACEUTICALS, INC.: 10-Q filed 2015-11-09

Name: INOVIO PHARMACEUTICALS, INC.: 10-Q filed 2015-11-09
Creator: INOVIO PHARMACEUTICALS, INC.

What INOVIO PHARMACEUTICALS, INC. reported in its quarterly report filed 2015-11-09 (fiscal Q3 2015): 43 published measures, 120 facts as tagged in accession 0001055726-15-000015.

This filing

Form: 10-Q (quarterly report)
Filed: 2015-11-09
Fiscal period: fiscal Q3 2015
Accession: 0001055726-15-000015 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All INOVIO PHARMACEUTICALS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2015-09-30	230,771,526	USD
At 2014-12-31	131,785,097	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2015-09-30	37,385,946	USD
At 2014-12-31	20,247,503	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2015-09-30	193,139,752	USD
At 2014-12-31	111,226,976	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2015-09-30	85,468,796	USD
At 2014-12-31	40,543,982	USD
At 2014-09-30	70,669,000	USD
At 2013-12-31	33,719,796	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	5,594,468	USD	92
2015-01-01 to 2015-09-30	-11,235,561	USD	273
2014-07-01 to 2014-09-30	-7,177,575	USD	92
2014-01-01 to 2014-09-30	-28,710,309	USD	273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	-5,664,962	USD	273
2014-01-01 to 2014-09-30	-21,749,106	USD	273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	1,955,621	USD	273
2014-01-01 to 2014-09-30	1,207,874	USD	273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	24,183,234	USD	92
2015-01-01 to 2015-09-30	34,636,549	USD	273
2014-07-01 to 2014-09-30	1,840,353	USD	92
2014-01-01 to 2014-09-30	7,999,658	USD	273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	84,192,310	USD	273
2014-01-01 to 2014-09-30	71,295,172	USD	273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	-33,602,534	USD	273
2014-01-01 to 2014-09-30	-12,595,173	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2015-09-30	-343,145,851	USD
At 2014-12-31	-331,910,290	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	72,029,644	shares	92
2015-01-01 to 2015-09-30	66,846,481	shares	273
2014-07-01 to 2014-09-30	60,392,911	shares	92
2014-01-01 to 2014-09-30	58,625,740	shares	273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	73,961,237	shares	92
2015-01-01 to 2015-09-30	67,018,961	shares	273
2014-07-01 to 2014-09-30	60,602,831	shares	92
2014-01-01 to 2014-09-30	58,936,414	shares	273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	0.08	USD/shares	92
2015-01-01 to 2015-09-30	-0.17	USD/shares	273
2014-07-01 to 2014-09-30	-0.12	USD/shares	92
2014-01-01 to 2014-09-30	-0.49	USD/shares	273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	0.07	USD/shares	92
2015-01-01 to 2015-09-30	-0.18	USD/shares	273
2014-07-01 to 2014-09-30	-0.12	USD/shares	92
2014-01-01 to 2014-09-30	-0.52	USD/shares	273

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-1,789,246	USD	92
2015-01-01 to 2015-09-30	-1,789,246	USD	273
2014-07-01 to 2014-09-30	0	USD	92
2014-01-01 to 2014-09-30	0	USD	273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2015-09-30	6,458,900	USD
At 2014-12-31	4,583,204	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	4,900,898	USD	273
2014-01-01 to 2014-09-30	4,548,445	USD	273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	3,730,417	USD	92
2015-01-01 to 2015-09-30	-19,757,287	USD	273
2014-07-01 to 2014-09-30	-8,331,166	USD	92
2014-01-01 to 2014-09-30	-28,484,167	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2015-09-30	184,073,414	USD
At 2014-12-31	98,947,084	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2015-09-30	18,277,872	USD
At 2014-12-31	14,023,752	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2015-09-30	10,113,371	USD
At 2014-12-31	10,113,371	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2015-09-30	4,118,010	USD
At 2014-12-31	4,776,059	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2015-09-30	10,965,273	USD
At 2014-12-31	2,804,207	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	20,452,817	USD	92
2015-01-01 to 2015-09-30	54,393,836	USD	273
2014-07-01 to 2014-09-30	10,171,519	USD	92
2014-01-01 to 2014-09-30	36,483,825	USD	273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	16,075,201	USD	92
2015-01-01 to 2015-09-30	42,190,032	USD	273
2014-07-01 to 2014-09-30	7,017,805	USD	92
2014-01-01 to 2014-09-30	24,850,566	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2015-09-30	72,180,794	shares
At 2014-12-31	60,741,082	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2015-09-30	532,559,242	USD
At 2014-12-31	443,327,915	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2015-09-30	3,654,180	USD
At 2014-12-31	-251,390	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit	Days
At 2015-09-30	193,385,580	USD
At 2014-12-31	111,537,594	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2015-09-30	4,118,010	USD
At 2014-12-31	4,776,059	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2015-09-30	597,570	USD
At 2014-12-31	474,568	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2015-09-30	2,942,444	USD
At 2014-12-31	2,007,432	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2015-09-30	1,348,890	USD
At 2014-12-31	797,973	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	3,805,222	USD	92
2015-01-01 to 2015-09-30	-12,940,038	USD	273
2014-07-01 to 2014-09-30	-7,179,061	USD	92
2014-01-01 to 2014-09-30	-28,727,646	USD	273

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	5,594,468	USD	92
2015-01-01 to 2015-09-30	-11,150,792	USD	273
2014-07-01 to 2014-09-30	-7,179,061	USD	92
2014-01-01 to 2014-09-30	-28,727,646	USD	273

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	9,572,840	USD	92
2015-01-01 to 2015-09-30	-7,329,991	USD	273
2014-07-01 to 2014-09-30	-7,240,388	USD	92
2014-01-01 to 2014-09-30	-28,744,120	USD	273

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	4,977,991	USD	92
2015-01-01 to 2015-09-30	-12,164,539	USD	273
2014-07-01 to 2014-09-30	-7,448,597	USD	92
2014-01-01 to 2014-09-30	-30,706,853	USD	273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	4,377,616	USD	92
2015-01-01 to 2015-09-30	13,203,804	USD	273
2014-07-01 to 2014-09-30	3,153,714	USD	92
2014-01-01 to 2014-09-30	11,633,259	USD	273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	733,722	USD	273
2014-01-01 to 2014-09-30	428,801	USD	273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	215,000	USD	92
2015-01-01 to 2015-09-30	658,049	USD	273
2014-07-01 to 2014-09-30	235,000	USD	92
2014-01-01 to 2014-09-30	712,121	USD	273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	81,902,363	USD	273
2014-01-01 to 2014-09-30	59,209,182	USD	273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	8,161,066	USD	273
2014-01-01 to 2014-09-30	-1,679,569	USD	273

Inspect the source

Entity: INOVIO PHARMACEUTICALS, INC. / CIK 0001055726
Captured: 2026-09-20T05:17:43.559Z
SEC response SHA-256: 9bfa830827e08b2d190e6d0b4ce0274a3c0d8852b6e536b16b5cfeadcaa54cf9

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001055726.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))